Top 7 Manufactures of Active Pharmaceutical Ingredient (API) for Pharmaceutic Drugs

Posted by : Admin 19-Jul-2022   474   0  

As per Business Intelligence Insights (BII) study, the global  Active Pharmaceutical Ingredient (API) Market  attained revenue growth of USD 175.2 billion in 2021 and it is projected to reach around USD 305.6 billion by 2030, growing at a 7.20% CAGR. Click here_to request a sample report containing detailed insights into market trends expected in the coming years.

The active pharmaceutical ingredient (API) is the component of a medicine that causes it to work. Combination therapies, for example, have various active substances that cure distinct symptoms or work in different ways. During both the R&D and commercial production phases, they are made employing highly technical industrial procedures. The expanding drug research and development activities for drug manufacturing, the increasing importance of generics, and the increasing consumption of biopharmaceuticals are the primary drivers driving the growth of the active pharmaceutical ingredients market. However, the market's expansion is likely to be hampered by unfavourable drug price control regimes in several countries and high manufacturing costs.

The rising frequency of chronic diseases is predicted to boost medicine demand, which will drive the active pharmaceutical ingredients market forward in the near future. Furthermore, new medication and biological product launches, acquisitions, collaborations, and regional expansions are some of the companies' strategic attempts to maintain market stability. Medications such as anti-infective, diabetic, cardiovascular, analgesics, and pain management drugs have long dominated the active pharmaceutical ingredients (API) industry. However, according to R&D trends, the demand for complex APIs employed in innovative formulations aimed at specific therapeutic areas is increasing. Drug price control measures in various countries, severe competition among current companies, and tight regulatory policies are among the primary factors constraining market expansion.

Pfizer Inc. is a pharmaceutical and biotechnology company headquartered in Manhattan, New York. It provides medicines to underserved communities that would not otherwise be available. The company was founded in New York in 1849 by two German immigrants, Charles Pfizer and his cousin Charles F. Erhart. Pfizer's CEO is Dr. Albert Bourla. To improve the discovery of small molecule drugs, their manufacture, and the production of active pharmaceutical ingredients (API), Pharmaceutical Sciences envisions a network of collaborators.

Teva Pharmaceutical Industries established in 1901, healthcare professionals, patients, and caregivers have been using our affordable, generic, and cutting-edge products. With around 3,600 products, they currently have one of the largest product portfolios of any pharmaceutical corporation in the world. Every day, one of Teva's high-quality medications helps about 200 million individuals in 60 different countries. Teva api is your ideal API partner, with the broadest global portfolio in the active pharmaceutical ingredients (API) industry and a track record of excellence spanning over 80 years. Kåre Schultz is the CEO of Teva Pharmaceutical Industries.

Novartis  is reimagining medicine to help people live longer and healthier lives. As a leading global pharmaceutical company, they use cutting-edge science and digital technologies to develop transformative treatments in areas of high medical need. From 2018, Vasant Narasimhan has been the CEO of Novartis. Nearly 800 million people around the world use Novartis pharmaceuticals, and they are constantly looking for new, creative methods to increase access to our most recent treatments. Novartis employs about 108,000 employees from more than 140 different countries worldwide. Kundl, Austria, increases production of oral antibiotics, while Palafolls, Spain, expands production of sterile active pharmaceutical ingredients.

Mr. P. V. Ramprasad Reddy, Mr. K. Nityananda Reddy, and a small group of highly committed professionals founded Aurobindo Pharma in 1986. Aurobindo Pharma is now a knowledge-driven company that produces active pharmaceutical ingredients and formulation products. Arvind Vasudeva is CEO of Aurobindo Pharma.

BASF was founded in 6 April 1865, Mannheim, Germany. Dr. Martin Brudermüller is the CEO of BAFE from 2018. Around 111,000 BASF Group employees contribute to the company's success. Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care, and Agricultural Solutions comprise BASF's portfolio. In 2021, BASF expects to generate €78.6 billion in sales. BASF offers the largest portfolio and largest variety of chemical raw materials in the world to meet the specific requirements of your API production.

Dr. Reddy's Laboratories was founded in 1984 in Hyderabad. Dr. Anji Reddy founded the company with an initial investment of Rs 25 lakh. Erez Israeli is the company's current CEO. Dr. Reddy's API business provides high-quality, low-cost APIs to leading generic formulations manufacturers around the world, allowing them to accelerate patient access to affordable medicines. We are a preferred API partner for pharmaceutical companies in the United States, Europe, Latin America, Japan, China, Korea, and emerging markets. There are more than 21,000 workers for the company worldwide. 

In 1983, Dilip Shanghvi established Sun Pharmaceuticals in Vapi, Gujarat. With global revenues of more than US$ 4.5 billion, Sun Pharmaceutical Industries Ltd. (Sun Pharma) is the fourth-largest specialty generic pharmaceutical firm in the world. Worldwide, there are 37,000+ employees. Sun Pharma manufactures APIs in 14 facilities across India, Hungary, the United States, Israel, and Australia. Their product line includes generics and complex APIs that require isolated manufacturing areas, such as anti-cancers, peptides, steroids, sex hormones, and controlled substances, as well as poppy-derived opiate raw materials used primarily in the manufacture of analgesics and sold as both Narcotic Raw Materials (NRM) and APIs.

 

---